Search
for
Sort by
Research 30 of 1000+
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- - Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Novel Fish Oil-based Bigel System for Controlled Drug Delivery and its Influence on Immunomodulatory Activity of Imiquimod Against Skin Cancer
- Cutaneous drug reactions
- Drug-induced postinfantile giant cell hepatitis
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Diagnostic challenges in determining alopecia areata
- Psoriatic onychopachydermoperiostitis: improvement with etanercept
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Lupus erythematosus: systemic and cutaneous manifestations
- Psoriatic Alopecia/Alopecia Areata‐Like Reactions Secondary to Anti‐Tumour Necrosis Factor‐Alpha Therapy
- The protective role of FTY720 in promoting survival of allograft fat in mice
- Ketoconazole-p Aminobenzoic Cocrystal Exhibits a Potent Anti-inflammatory Effect on the Skin of BALBc Mice
- ANALYSIS OF THE BACKGROUND LEVEL OF CYTOKINES M1 AND M2 OF THE MACROPHAGE PHENOTYPE IN PATIENTS WITH REVISION RHINOPLASTY AFTER THE USE OF THE DRUG PDRN
- Efficacy of Glycyrrhetinic Acid in the Treatment of Acne Vulgaris Based on Network Pharmacology and Experimental Validation
- A Soy-Derived Immunostimulating Peptide Inhibits Etoposide-Induced Alopecia in Neonatal Rats
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- P07 Pityriasis amiantacea: a unique presentation of psoriasis associated with tumour necrosis factor-α inhibitor therapy
- LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
- ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients
- Drug Discovery Today: Therapeutic Strategies - 2006 Editorial
- Psoriatic Skin Lesions Induced by Certolizumab Pegol
- Cepharanthine loaded nanoparticles coated with macrophage membranes for lung inflammation therapy
- Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury
- Adverse Effects and Drug Interactions of Biologic Agents
- Evaluation of Antiarthritic and Antinociceptive Effects of Cedrol in a Rat Model of Arthritis